RoboTrak Medical's Xingjing® and Haojing® Spark Enthusiasm at ARVO 2025 as the Company Accelerates Global Expansion

May 07, 2025 18:32 CST Updated 18:32

Robotrak Technologies

Ophthalmic Medical Device R&D Developer

Click the blue words above to follow us

Abstract

Recently,The 2025 Annual Meeting of the Association for Research in Vision and Ophthalmology (ARVO) was grandly held in Salt Lake City, Utah, USA.

At this global top-tier ophthalmology and vision science conference, Herb-invested company "Robotrak Technologies" once again became the focus with its StarMirror® and BrightMirror®.

Robotrak Technologies Booth: 1819

As the top academic event in the field of international ophthalmology and vision research, the ARVO Annual Meeting has become an authoritative platform for the fusion of top scientific research intelligence worldwide, gathering cutting-edge international ideas and showcasing the latest research achievements.As a First-in-Class full-age-range ophthalmic innovation platform enterprise, Robotrak Technologies has showcased its innovative application achievements to the world, such as the adaptive optics fundus imaging system and the small animal ophthalmic multi-modal imaging system.

StarLens®Adaptive Optics Fundus Imaging System

As the first AO-SLO fundus imaging device in the industry to obtain a medical device registration certificate, the **Stellaris® Adaptive Optics Fundus Imaging System** has drawn widespread attention since its debut due to its exceptional technical features. The device enhances the lateral resolution of fundus images to 0.7 micrometers, enabling real-time observation of individual retinal cells in the human eye. It can be used for studying disease pathogenesis, ultra-early diagnosis, intervention, follow-up observations, and evaluating innovative therapies such as gene and stem cell treatments, earning it the reputation of being an "in vivo fundus biomicroscope."

Haojing® Small Animal Ophthalmic Multi-Modal Imaging System

As the first integrated SLO and OCT multi-channel fundus imaging platform in China specifically designed for small animals, this device employs non-invasive imaging to help reduce animal sacrifice in animal experiments, continuously track the effects of drug administration, lower the cost of animal experiments, improve the efficiency of gene therapy drug development, and accelerate the innovative transformation of new gene therapy treatments.

The grand occasion of ARVO 2025 is a microcosm of Robotrak Technologies' global strategy.The booth attracted a steady stream of visitors and international partners — the power of Chinese technology is shining on the world stage.

Previous Recommendations

First in China｜Robotrak Technologies' ZhiGuang® Intelligent Retinal Navigation Laser Approved for Marketing by NMPA

StellarVue® First Commercial Adaptive Optics Retinal Imaging System, Robotrak Technologies Receives Multiple Honors from the China Medical Equipment Association | BettaPharm Investee

100+ Portfolio Ecosystem

Innovative Pharmaceuticals/Biotechnology

BioSense‍‍

Herbal Bada

Yiming Biologics

Purinomia

ITabMed

AcroImmune

Libang Pharmaceuticals

Shandun Pharmaceuticals

MicuRx Pharmaceuticals

OncoC4

Xunji Bio‍‍

EpimAb Biotherapeutics

Larkspur

Lipidio

Henry Pharmaceuticals

Ansun

Enrui Ni‍‍

New Modalities‍

C4T‍‍‍‍‍

Blue Magpie Biotech

Cullgen‍‍‍‍

Zehui Bio

Rapafusyn‍‍‍‍‍‍‍‍‍‍‍‍‍

Antor Bio

Xiantong Pharmaceuticals‍‍‍‍‍

Avirmax‍‍‍‍

Life Science Tools

Cytek‍

Saiqiao Biotech‍

Naxi Technologies

Gewu Zhihe

Genotix

Robotrak Technologies

IVD/Innovative Medical Devices

Kai Ai Health

Liget

Carlight Biotech

Haiskell‍‍‍‍‍‍‍‍‍

Virtue Precision

Noliving Biotech

Ophthalmology/Medical Aesthetics/Consumer Healthcare‍

Aiborn Technologies

Acclaro

Dermaliq

Robotrak Technologies‍‍‍‍

RuiMu Biotech‍‍

Yuxi Pharmaceuticals‍

Smartlens

Zhengli Technologies

Pharmaceutical and R&D Industry Chain

Biocytogen

Sincerity CRO‍‍‍‍‍‍‍‍‍‍

Opmay‍‍

Pharmacodia

Jingyu Group

‍

Huacan Biotech

Kaike Biotech

Brain Science/Central Nervous System (CNS)

Ubralink

Quadriga

Myrobalan‍‍‍

Dr. Zhaoyang‍‍

Cognition

Lysoway

Regenacy

AI/Home Health Monitoring/Data‍‍

Little Fly Technology

Lingtong Technology

Tianwu Technologies

Wenxin Technology

Deep Intelligence Medical‍‍‍

CrystalClear Technologies

Sentieon

Medtronic

Geneis Orient

Profusa

Synthetic Biology/Bio-Industry

Twist‍

Sipon Technology

VentureLab

Polytree Bio

Xunyuan Technology

Biological Agriculture / Animal Health

Nabio Biotech

Wangdu Bio

Dingchi Bio

Qingyuan Nongguan

Oubot

Materia MedicaResourcesThisFocused on investing in hard-core technological innovations in the global life sciences sector. We allocate approximately half of our investments to Biotech, which refers to innovative pharmaceuticals, including novel drug modalities and drug discovery platforms; the other half is dedicated to TechBio, representing disruptive innovations arising from cross-disciplinary technology integration, including but not limited to IT technologies, sensors, data science, artificial intelligence, and their convergence with biology to create next-generation devices, diagnostic tools, and life science research instruments. Based in China and targeting the global market, Bencao aims to advance cutting-edge technological progress in the life sciences field and make a positive contribution to human health and well-being.

Focus on 「Herbal Capital"】WeChat Official Account and set it as 'Star ⭐' to get the latest updates第一时间收获最新推送"